Coherus Oncology (8C5.F) Q4 2023 Earnings

13MarConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.65
-0.5
-0.34
-0.19

Details

Expected EPS
-0.18889367658
Actual EPS
-0.6481874
Surprise EPS
-0.46
Surprise Percent
+243.15%

Description

Coherus Oncology (8C5.F) has reported earnings of -0.6481874 per share for Q4 2023.

0 Comments

Share your thoughts